Articles tagged with "JAK inhibitors"

ACR Convergence 2020

Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities

January 25, 2021 • By Mary Beth Nierengarten

Upadacitinib Safety Similar to Other Jakinibs for RA

November 16, 2020 • By Lisa Rapaport

Janus Kinase vs. TNF Inhibitors: The Context for Venous Thromboembolism Risk with RA Treatments

October 7, 2020 • By Larry Beresford

Year in Review: Rheumatic Disease Research in 2019

November 20, 2019 • By Thomas R. Collins

Lilly’s Lupus Treatment Succeeds in Mid-Stage Trial

June 14, 2018 • By Tamara Mathias

AbbVie’s Rheumatoid Arthritis Drug Succeeds in Late-Stage Trial

June 7, 2017 • By Reuters Staff

Baricitinib Has Promising Clinical Trial Results for Treating RA

May 18, 2016 • By Michele B. Kaufman, PharmD, BCGP

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

July 1, 2014 • By Gretchen Henkel

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

June 1, 2013 • By Deborah L. Parks, MD

Rheumatology Drug Updates: Apremilast, Golimumab, and More

November 1, 2012 • By Michele B. Kaufman, PharmD, BCGP